CTC North GmbH & Co. KG, Am Universitätsklinikum Hamburg-Eppendorf

Hamburg 20251

0 studies enrolling now · 3 studies all time

What they study most

Crohn Disease, Crohn's Disease, Hemophilia A, Ulcerative Colitis

Studies at this site

• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis — Stopped early
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors — Completed